Lung Cancer Translational and Integrative Pathobiology Lab

at the Centre de Recherche Institut universitaire de cardiologie et

de Pneumologie de Québec (IUCPQ) – Université Laval

Illuminating the Tumor Microenvironment to Transform Lung Cancer Care

Our Mission

We integrate spatial biology, molecular pathology, and computational analytics to decode the complexity of lung tumors and accelerate precision medicine. Our lab bridges clinical insight with cutting-edge research to drive innovation in lung cancer diagnosis, prognosis and treatment.

Translational and Integrative Research

We investigate the earliest biological signals of lung cancer to improve detection and understand disease progression. Our lab explores the tumor microenvironment’s role in shaping cancer behavior, using cutting-edge spatial, computational, and multi-omics technologies to analyze patient tissues. By integrating pathology with advanced data science, we aim to uncover actionable insights that drive precision medicine and collaborative innovation.

Our Research

Why IUCPQ Is a Unique Hub for Lung Cancer Research?

Serving over 2.2 million residents across Central and Eastern Québec, IUCPQ is a leading center for specialized care in pulmonary, cardiac, and obesity-related diseases. Its Respiratory Unit brings together a powerhouse team of 24 respirologists (including 7 pneumo-oncologists), 4 thoracic surgeons, and 6 expert pathologists, making lung cancer one of its core clinical missions.

Each year, IUCPQ diagnoses 800–900 new lung cancer cases, with 400–450 surgical resections and 3,200 patients undergoing molecular testing—making its pathology lab one of the largest in Canada. This exceptional patient volume, combined with a deeply integrated multidisciplinary team, creates a fertile ground for prospective studies, biomarker validation, and translational breakthroughs in lung cancer care.

Page updated

Google Sites

Report abuse